Fan Pharmaceutical's half -year losses in 2022 losses 1,183,900 yuan in losses, a loss of 415.04% year -on -year
Author:Capital state Time:2022.08.20
On August 18, He Fan Pharmaceutical (Code: 833012.NQ) released the performance report of the 2022 Half -Annual Report.
From January 1, 2022-June 30, 2022, the company realized operating income of 11.1276 million yuan, a year-on-year decrease of 1.30%, net loss of 11.839 million yuan, and a loss of 415.04%year-on-year, and the basic earnings per share were -0.0300 yuan.
The company's industry is chemical pharmaceutical.
During the company's reporting period, the total assets at the end of the period were 89.3618 million yuan, the operating profit was -11.893 million yuan, and the accounts receivable was 1.564 million yuan. The net cash flow generated by operating activities was -2.455 million yuan.The cash he arrived was 13.2371 million yuan.
Fan Fan Pharmaceutical, the company's full name Zhuhai and Fan Pharmaceutical Co., Ltd., was established on July 25, 2003. The current general manager Fan Wei is the main business of research and development and sales of drugs to transfer patent trademarks and other technical use services.
- END -
"Sit" in front of the old man's table to "sit" out of the pulmonary embolism, doctor: avoid sedentary and long stand, the weather is hot and hydrating
Wuhan Evening News July 27th News The front of the table was a whole day. Recently...
Why is the mental exhaustion with excessive brain?
Time of meditation often makes people feel tired. Why is this? Recently, a new study by French researchers found that long -term attention concentration will cause glutamic acid to accumulate in the f